5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)wet macular degenerationRecruitingPhase 32026-08-06NCT07317934
Phase III Study of OT202 in Treating Moderate to Severe Dry Eyedry eye syndrome, eye disorder, lacrimal apparatus disorderNot yet recruitingPhase 32026-07-31NCT07740564
A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treating Chinese Children With Severe Plaque PsoriasisAdult Non-infectious UveitisRecruitingPhase 42026-07-15NCT07663331
TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular DegenerationNeovascular Age-related Macular DegenerationActive, not recruitingPhase 32025-01-07NCT05461339
Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)Neovascular Age-related Macular DegenerationRecruitingPhase 1 / Phase 22024-11-14NCT06141460